L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model

Both active tuberculosis (TB) and asymptomatic latent Mycobacterium tuberculosis (M. tb) infection (LTBI) cause significant health burdens to humans worldwide. Individuals with immunocompromising health conditions, such as Type 2 Diabetes Mellitus (T2DM), have a weakened ability to control M. tb inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Beever, Abrianna, Kachour, Nala, Owens, James, Sasaninia, Kayvan, Kolloli, Afsal, Kumar, Ranjeet, Ramasamy, Santhamani, Sisliyan, Christina, Khamas, Wael, Subbian, Selvakumar, Venketaraman, Vishwanath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263396/
https://www.ncbi.nlm.nih.gov/pubmed/35814213
http://dx.doi.org/10.3389/fphar.2022.879729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263396/
https://www.ncbi.nlm.nih.gov/pubmed/35814213
http://dx.doi.org/10.3389/fphar.2022.879729

Ejemplares similares